Market Leads & Opportunities
United Kingdom-Runcorn: Pharmaceutical products – Framework Lead
The current contract for Pharmaceutical products – Framework Lead is projected to end on 02-OCT-18 and may be available for retender.
Description:
Title attributed to the contract by the contracting authority:: NHS Framework Agreement for the South Of England Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals – Tranche B.
Type of contract and location of works, place of delivery or of performance: Supplies
Purchase
Main site or location of works, place of delivery or of performance: The framework agreement is intended for use by the Department of Health and the NHS in England.
The framework may also be used by private sector contractors and agents working on behalf of the above.
Please refer to Document 10a in the ITO documents for the list of participating authorities.
NUTS code
Information on framework agreement: Framework agreement with several operators
Duration of the framework agreement
Duration in years: 4
Estimated total value of purchases for the entire duration of the framework agreement
Estimated value excluding VAT:
Range: between 200 000 000 and 400 000 000 GBP
Short description of the contract or purchase(s): NHS Framework Agreement for the South Of England Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals – Tranche B.
1 September 2014 – 31 August 2016 with an option to extend for 2 years.
Information about variants: Variants will be accepted: yes
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre. - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million.
